Loading...

STSS SHARPS TECHNOLOGY INC Company Mergers 8-K Filing

SHRP

STSS

SHARPS TECHNOLOGY INC

(STSS)

2023 8-K

Show Summary

Show Summary

Reverse Stock Split

Investor Meetings

Nasdaq Compliance

Public Offering

Nasdaq Compliance

Public Offering

Shareholder Voting

Warrant Approval

Delisting Notice

Public Offering

Bylaw Amendment

Annual Meeting Results

Bylaw Amendment

Press Release Issued

Stock Split Proposal

Press Release Issued

Securities Agreement

Amendment to Articles of In...

Supply Agreement with Steri...

Meeting Results

Investment Agreement

Investment Agreement

Correction and Warrant Indu...

Regulation FD Disclosure

Warrant Inducement Agreement

Regulation FD Disclosure

Agreements with Nephron SC ...

Cooperative Sales and Distr...

Resignation of Previous Ind...

Annual Meeting Approval

Asset Purchase Agreement wi...

Elimination of floor price ...

Departure of Directors

External Links:

Sharps Technology Inc. entered into an asset purchase agreement with Nephron Pharmaceuticals Corporation to purchase equipment and leasehold improvements at Nephron's facility in South Carolina for a cash price of $40,378,594 and a promissory note of

AI Assistant

SHARPS TECHNOLOGY INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.